Login / Signup

Factors affecting sufentanil consumption for intravenous controlled analgesia after hepatectomy: retrospective analysis.

Yue WuLina TianChunye LiMinjun LiuShina QiaoWeibo ZhangSuming TianGang Chen
Published in: BMC anesthesiology (2021)
Age younger than 60 years, major hepatic resection, an open approach and a longer operation are factors more likely to cause patients to require higher doses of sufentanil after hepatectomy, and the early identification of such patients can increase the efficacy of perioperative pain management.
Keyphrases
  • pain management
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • cardiac surgery
  • patient reported outcomes
  • patients undergoing
  • high dose